嗜碱性粒细胞百分比与慢性肾脏病关系的回顾性队列研究
Association between basophils percentage and chronic kidney disease: a retrospective cohort study

DOI: 10.6040/j.issn.1671-7554.0.2017.1040

Keywords: 嗜碱性粒细胞百分比,队列,Cox回归,慢性肾脏病,健康管理人群,
Chronic kidney disease,Basophils percentage,Cohort,Cox regression,Health management population

Full-Text   Cite this paper   Add to My Lib

Abstract:

References

[1]	Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612.
[2]	Kidney Disease: Improving Global Outcomes(KDIGO)CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J]. Kidney Int Suppl, 2013, 3(1): 1-150.
[3]	Tian N, Penman AD, Manning RJ, et al. Association between circulating specific leukocyte types and incident chronic kidney disease: the Atherosclerosis Risk in Communities(ARIC)study[J]. J Am Soc Hypertens, 2012, 6(2): 100-108.
[4]	中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中国循环杂志, 2016, 31(10): 937-953.
[5]	Shen ZW, Xing J, Wang QL, et al. Association between serum gamma-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study[J]. Int Urol Nephrol, 2017, 49(2): 303-312.
[6]	Pecaric-Petkovic T, Didichenko SA, Kaempfer S, et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33[J]. Blood, 2009, 113(7): 1526-1534.
[7]	Wang F, Zhang L, Wang H. Awareness of CKD in China: a national cross-sectional survey[J]. Am J Kidney Dis, 2014, 63(6): 1068-1070.
[8]	Wang F, Ye P, Xiao WK, et al. Association of risk factors for cardiovascular disease and the rate of glomerular filtration: a cross-sectional study in the population from certain areas of Beijing[J]. Chin J Epidemiol, 2010, 31(3): 256-259.
[9]	Kang HT, Kim JK, Shim JY, et al. Low-grade inflammation, metabolic syndrome and the risk of chronic kidney disease: the 2005 Korean National Health and Nutrition Examination Survey[J]. J Korean Med Sci, 2012, 27(6): 630-635.
[10]	Yamanishi Y, Karasuyama H. Basophil-derived IL-4 plays versatile roles in immunity[J]. Semin Immunopathol, 2016, 38(5): 615-622.
[11]	Agarwal R, Light RP. Patterns and prognostic value of total and differential leukocyte count in chronic kidney disease[J]. Clin J Am Soc Nephrol, 2011, 6(6): 1393-1399.
[12]	Li B, Haridas B, Jackson AR, et al. Inflammation drives renal scarring in experimental pyelonephritis[J]. Am J Physiol Renal Physiol, 2017, 312(1): F43-F53.
[13]	MacGlashan DJ. IgE receptor and signal transduction in mast cells and basophils[J]. Curr Opin Immunol, 2008, 20(6): 717-723.
[14]	Park YS. Renal scar formation after urinary tract infection in children[J]. Korean J Pediatr, 2012, 55(10): 367-370.
[15]	Webster AC, Nagler EV, Morton RL, et al. Chronic kidney disease[J]. Lancet, 2017, 389(10075): 1238-1252.
[16]	Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease-a systematic review and meta-analysis[J]. PLoS One, 2016, 11(7): e158765. doi: 10.1371/journal.pone.0158765.
[17]	Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818): 815-822.
[18]	Sepanlou SG, Barahimi H, Najafi I, et al. Prevalence and determinants of chronic kidney disease in northeast of Iran: Results of the Golestan cohort study[J]. PLoS One, 2017, 12(5): e176540. doi:10.1371/journal.pone.0176540.
[19]	Shankar A, Sun L, Klein BE, et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study [J]. Kidney Int, 2011, 80(11): 1231-1238.
[20]	Miyake K, Karasuyama H. Emerging roles of basophils in allergic inflammation[J]. Allergol Int, 2017, 66(3): 382-391.
[21]	Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal[J]. Clin J Am Soc Nephrol, 2009, 4(Suppl 1): S49-S55.
[22]	Gungor O, Unal HU, Guclu A, et al. IL-33 and ST2 levels in chronic kidney disease: associations with inflammation, vascular abnormalities, cardiovascular events, and survival[J]. PLoS One, 2017, 12(6): e178939. doi:10.1371/journal.pone.0178939.
[23]	刘娅飞,邢娉,徐秀琴,等. 山东多中心健康管理纵向观察队列[J]. 山东大学学报(医学版),2017, 55(6): 30-36. LIU Yafei, XING Ping, XU Xiuqin, et al. Shandong multi-center longitudinal cohort for health management: a brief introduction[J]. Journal of Shandong University(Health Sciences), 2017, 54(7): 30-36.
[24]	中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管病杂志, 2011, 39(7): 579-616. Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension[J]. Chin J Cardiol, 2011, 39(7): 579-616.
[25]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华糖尿病杂志, 2014, 6(7): 447-498.

Full-Text